Kathrin Heinzmann
Cancer Research UK(GB)
Publications by Year
Research Areas
Cancer, Hypoxia, and Metabolism, Lung Cancer Treatments and Mutations, Cancer Mechanisms and Therapy, Cancer-related Molecular Pathways, Medical Imaging Techniques and Applications
Most-Cited Works
- → An empirical framework for binary interactome mapping(2008)904 cited
- → A Phase I Dose-escalation Study of AZD3965, an Oral Monocarboxylate Transporter 1 Inhibitor, in Patients with Advanced Cancer(2023)190 cited
- → Multiplexed imaging for diagnosis and therapy(2017)167 cited
- → AT13148 Is a Novel, Oral Multi-AGC Kinase Inhibitor with Potent Pharmacodynamic and Antitumor Activity(2012)91 cited
- → Clinical translation of [18F]ICMT-11 for measuring chemotherapy-induced caspase 3/7 activation in breast and lung cancer(2018)43 cited
- → Preclinical Applications of 3'-Deoxy-3'-[18F] Fluoro-thymidine in Oncology - A Systematic Review(2016)35 cited
- → Phase I expansion study of the first-in-class monocarboxylate transporter 1 (MCT1) inhibitor AZD3965 in patients with diffuse large B-cell lymphoma (DLBCL) and Burkitt lymphoma (BL).(2021)34 cited
- → Variability of Proliferation and Diffusion in Different Lung Cancer Models as Measured by 3′-Deoxy-3′-18F-Fluorothymidine PET and Diffusion-Weighted MR Imaging(2014)22 cited
- → Gemcitabine Mechanism of Action Confounds Early Assessment of Treatment Response by 3′-Deoxy-3′-[18F]Fluorothymidine in Preclinical Models of Lung Cancer(2016)19 cited
- → Tracing Nutrient Flux Following Monocarboxylate Transporter-1 Inhibition with AZD3965(2020)17 cited